Moderna misses on earnings as costs rise from surplus production capacity, lower Covid shot demand – CNBC

by

  1. Moderna misses on earnings as costs rise from surplus production capacity, lower Covid shot demand CNBC
  2. Sliding vaccine sales, new costs, shrink Moderna 4Q profit Yahoo Finance
  3. Moderna co-founder talks COVID-19 vaccines, mRNA growth, agriculture portfolio Yahoo Finance
  4. Moderna earnings fall short of estimates amid steep decline in COVID vaccine sales, expects to file for approval of RSV vaccine in first half MarketWatch
  5. Moderna stock dips as Q4 earnings fall; reaffirms COVID vaccine sales outlook of $5B Seeking Alpha
  6. View Full Coverage on Google News

Read original article here

Leave a Comment